Sigma hits profit falls

SIGMA Healthcare’s full-year profit has fallen by a third to $36.5 million after the drugs wholesaler started restructuring in response to the loss of its supply deal to Chemist Warehouse pharmacies.

Sigma, which this month rebuffed a merger proposal by Priceline owner Australian Pharmaceuticals Industries, recorded $9.2 million in posttax restructuring and dual operating costs.